89亿美元巨额分红背后:科兴生物九年“内斗”将如何收场?

澎湃新闻
26 Jul

因为一场巨额分红,科兴生物重回舆论焦点。7月23日晚,未名医药(ST未名,002581)公告称,已与杭州强新生物科技有限公司(简称“杭州强新”)达成和解。杭州强新已同意将工商登记中厦门未名34%的股权无偿转让给未名医药。厦门未名曾持有北京科兴生物制品有限公司(简称“北京科兴”)约26%的股权。强新资本于2022年宣布收购厦门未名34%股权,被视为强新资本进入科兴体系的关键一步。近期,科兴两大董事会...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10